Revenue: The sum of all revenue fields included for a company's operating activities.
Organogenesis (ORGO) had Revenue of $482.04M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$482.04M |
$-0.94M |
|
$115.74M |
|
$366.30M |
|
$483.33M |
|
$-1.28M |
|
$-1.52M |
|
$-2.81M |
|
$-2.81M |
|
$0.86M |
|
$0.86M |
|
$0.86M |
|
$0.86M |
|
$-1.28M |
|
$24.09M |
|
131.67M |
|
131.67M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$285.94M |
|
$89.13M |
|
$211.94M |
|
$497.89M |
|
$77.48M |
|
$0.72M |
|
$157.51M |
|
$234.99M |
|
$262.90M |
|
$221.66M |
|
$262.90M |
|
125.73M |
|
| Cash Flow Statement Financials | |
$14.21M |
|
$-10.03M |
|
$27.64M |
|
$104.34M |
|
$136.15M |
|
$31.81M |
|
$10.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.69 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
75.99% |
|
-0.27% |
|
-0.27% |
|
5.00% |
|
-0.58% |
|
-0.19% |
|
$4.18M |
|
-- |
|
-- |
|
-- |
|
0.97 |
|
4.41 |
|
4.39 |
|
83.19 |
|
0.33% |
|
0.39% |
|
0.17% |
|
0.33% |
|
$2.09 |
|
$0.03 |
|
$0.11 |
|